Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases
Next-generation CRISPR genome editing • allogeneic CAR-T cell therapies • iPSC-derived NK cell therapies • oncology
51 - 200
💰 $125M Post-IPO Equity on 2023-07
5 days ago
51 - 200
Field Medical Affairs Director for Caribou's cellular therapy pipeline.
🇺🇸 United States – Remote
💵 $200k - $220k / year
💰 $125M Post-IPO Equity on 2023-07
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
🗽 H1B Visa Sponsor
5 days ago
51 - 200
Field Medical Affairs Director for Caribou's cellular therapy pipeline.
🇺🇸 United States – Remote
💵 $200k - $220k / year
💰 $125M Post-IPO Equity on 2023-07
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
🗽 H1B Visa Sponsor
Join our Facebook group
👉 Remote Jobs Network